Holen Sie sich die Stockscreener-App
16.98
2.23%
0.37
Schlusskurs vom Vortag:
$16.61
Offen:
$16.86
24-Stunden-Volumen:
45,623
Relative Volume:
0.48
Marktkapitalisierung:
$218.12M
Einnahmen:
$16.96M
Nettoeinkommen (Verlust:
$-23.88M
KGV:
-8.0973
EPS:
-2.097
Netto-Cashflow:
$-20.66M
1W Leistung:
-0.12%
1M Leistung:
-2.69%
6M Leistung:
-4.07%
1J Leistung:
+1.92%
1-Tages-Spanne:
$16.79
$17.37
1-Wochen-Bereich:
$16.38
$17.37
52-Wochen-Spanne:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
16.98 | 218.12M | 16.96M | -23.88M | -20.66M | -2.097 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-02 | Eingeleitet | Alliance Global Partners | Buy |
| 2025-02-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-07-16 | Bestätigt | Maxim Group | Buy |
| 2022-12-22 | Eingeleitet | Maxim Group | Buy |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-09-23 | Eingeleitet | BTIG Research | Buy |
| 2016-11-28 | Eingeleitet | Aegis Capital | Buy |
| 2016-08-17 | Eingeleitet | Wells Fargo | Outperform |
| 2014-04-16 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
MediWound (MDWD) director details options, RSU and share holdings - Stock Titan
MediWound Ltd. (NASDAQ:MDWD) Q4 2025 earnings call transcript - MSN
Gap Down: Can MediWound Ltd keep up with sector leaders2026 Sector Review & Smart Swing Trading Alerts - baoquankhu1.vn
Pullback Watch: Does MediWound Ltd meet Warren Buffetts criteriaEarnings Overview Report & Weekly Consistent Profit Watchlists - baoquankhu1.vn
MediWound (NASDAQ:MDWD) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Discipline and Rules-Based Execution in MDWD Response - Stock Traders Daily
Aug Drivers: Will MediWound Ltd outperform the market in YEARGap Down & Verified Short-Term Plans - baoquankhu1.vn
MediWound (MDWD) director Rubinstein reports options and share holdings - Stock Titan
[Form 3] MediWound Ltd. Initial Stateme... - Stock Titan
MediWound (MDWD) CMO details options and RSU awards in Form 3 filing - Stock Titan
MediWound Ltd. (MDWD) director discloses shares, RSUs and options stake - Stock Titan
MediWound (MDWD) VP reports stock options and RSU holdings in Form 3 - Stock Titan
MediWound (MDWD) EVP Meyer Yaron files Form 3 on equity holdings - Stock Titan
MediWound (MDWD) details director Stephen Wills’ initial share and option holdings - Stock Titan
MediWound (MDWD) COO Shmuel details option and RSU holdings in Form 3 - Stock Titan
MediWound (MDWD) CEO details warrants, RSUs and options in Form 3 - Stock Titan
MediWound (MDWD) director Nachum Shamir details shares, RSUs and options - Stock Titan
MediWound (MDWD) Stock Price, News & Analysis - MarketBeat
Medical Maggots Market Hits New High | Major Giants BioMonde, Maggot Therapy, MediWound - openPR.com
Menora Mivtachim Holdings LTD. Purchases 61,039 Shares of MediWound Ltd. $MDWD - MarketBeat
Rosalind Advisors Inc. Buys 341,993 Shares of MediWound Ltd. $MDWD - MarketBeat
Performance Recap: Is MediWound Ltd forming a bullish divergenceDip Buying & AI Optimized Trading Strategy Guides - baoquankhu1.vn
FY2030 Earnings Estimate for MediWound Issued By Maxim Group - Defense World
Institution Moves: Does MediWound Ltd meet Warren Buffetts criteria2026 Earnings Impact & Advanced Swing Trade Entry Plans - baoquankhu1.vn
FY2030 Earnings Forecast for MediWound Issued By Maxim Group - MarketBeat
MediWound Is the Biotech Governments Have Been Stockpiling for E - GuruFocus
MediWound Is the Biotech Governments Have Been Stockpiling for Exactly These Kinds of Wars (NASDAQ: MDWD) - TipRanks
MediWound outlines $24M–$26M 2026 revenue target while expanding EscharEx clinical programs - MSN
MediWound (MDWD) Q4 2025 Earnings Call Transcript - AOL.com
MDWD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MediWound Ltd. (NASDAQ:MDWD) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Behavioral Patterns of MDWD and Institutional Flows - Stock Traders Daily
MediWound (NASDAQ:MDWD) Stock Rating Lowered by Wall Street Zen - MarketBeat
MediWound Ltd. (NASDAQ:MDWD) Q4 2025 Earnings Call Transcript - Insider Monkey
MediWound: Q4 Earnings Snapshot - theheraldreview.com
MediWound Files Annual Report on Form 20-F - The Manila Times
Mediwound earnings beat by $0.03, revenue fell short of estimates - Investing.com Australia
MediWound Q4 Earnings Call Highlights - MarketBeat
MediWound (MDWD) Heavy FY 2025 Losses Test High Growth And Premium P/S Narrative - simplywall.st
MediWound Q4 2025 Earnings Call Transcript - MarketBeat
MediWound Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance
MediWound (NASDAQ:MDWD) Issues Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
MDWD: Expanded manufacturing, clinical progress, and strong guidance despite 2025 revenue decline - TradingView
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
MediWound (MDWD) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
MDWD Maintains Revenue Forecasts Through 2028 - GuruFocus
MediWound (MDWD) Reports Lower-than-Expected Q4 Revenue - GuruFocus
MediWound: Overview of Fourth Quarter Financial Results - Bitget
MEDIWOUND ($MDWD) Releases Q4 2025 Earnings - Quiver Quantitative
MediWound Posts 2025 Loss but Strengthens Cash and Advances EscharEx, NexoBrid Capacity - TipRanks
MediWound (NASDAQ: MDWD) posts 2025 loss with cash rising above $53M - Stock Titan
Finanzdaten der Mediwound Ltd-Aktie (MDWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):